PHAL Share Price Performance
SEK 0
0.00 (0.00%)
Price SEK 0
Share Pricen/a
PharmaLundensis AB Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PHAL Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
PharmaLundensis AB Key Details
Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
May 16, 2024
- -0.10
- 0%
- 0%
- 163.1%
About PHAL
- Founded
- 2006
- Employees
- 1
- CEO
- WebsiteView website
PharmaLundensis AB operates as a pharmaceutical company. The company develops Iodocarb for treating chronic obstructive pulmonary disease; and treatments for chronic bronchitis and influenza-induced lung failure. It develops EcoFilter, a system that eliminates the release of pharmaceutical drugs and multi-resistant bacteria in hospital wastewater. PharmaLundensis AB was founded in 2006 and is based in Lund, Sweden.
